Phase I study of bortezomib plus ICE (BICE) for the treatment of relapsed/refractory Hodgkin lymphoma

Michelle Fanale*, Luis Fayad, Barbara Pro, Felipe Samaniego, Mary Joy Liboon, Cesar Nunez, Sandra Horowitz, Paolo Anderlini, Uday Popat, Yuan Ji, Larry W. Kwak, Anas Younes

*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I study of bortezomib plus ICE (BICE) for the treatment of relapsed/refractory Hodgkin lymphoma'. Together they form a unique fingerprint.